Literature DB >> 2399896

Atrial flutter in patients treated for atrial fibrillation with propafenone.

C J Murdock1, A E Kyles, J A Yeung-Lai-Wah, A Qi, S Vorderbrugge, C R Kerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2399896     DOI： 10.1016/0002-9149(90)91144-u

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  17 in total

Review 1.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Atrial Flutter, Typical and Atypical: A Review.

Authors:  Francisco G Cosío
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 3.  [Pharmacological cardioversion of atrial fibrillation].

Authors:  J R Ehrlich; S H Hohnloser
Journal:  Z Kardiol       Date:  2005-01

4.  Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.

Authors:  M Biffi; G Boriani; G Bronzetti; A Capucci; A Branzi; B Magnani
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

5.  Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation.

Authors:  G P Kimman; T Szili-Torok; M Nieuwdorp; D A M J Theuns; M Scholten; L Jordaens
Journal:  Neth Heart J       Date:  2002-01       Impact factor: 2.380

Review 6.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

8.  Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.

Authors:  F Bellandi; R P Dabizzi; F Cantini; M D Natale; L Niccoli
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

9.  Limitations to antiarrhythmic drug use in patients with atrial fibrillation.

Authors:  Karin H Humphries; Charles R Kerr; Michael Steinbuch; Paul Dorian
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

Review 10.  Clinical pharmacokinetics of propafenone.

Authors:  J T Hii; H J Duff; E D Burgess
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.